US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.47

+0.06200.18%

Post-market: 34.46-0.0120-0.03%19:30 EDT

Volume:17.43K

Turnover:602.34K

Market Cap:95.83M

PE:- -

High:34.93

Open:34.93

Low:34.46

Close:34.41

52wk High:36.84

52wk Low:23.42

Shares:2.78M

Float Shares:2.78M

Volume Ratio:0.82

T/O Rate:0.63%

Dividend:0.26

Dividend Rate:0.75%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

UK Regulator Suspends Avacopan Vifor for New Patients

MT Newswires Live

Novartis halts autoimmune CAR-T trials following three deaths, Reuters says

Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs

UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September

THOMSON REUTERS

Zhifei Biological's Freeze-Dried Rabies Vaccine Candidate Receives Clinical Trial Application Acceptance

Centergate Subsidiary Gains Clinical Trial Clearance for Methylphenidate Prolonged-Release Chewable Tablet

Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?

Simply Wall St.

Novartis Faces Dual Outcomes: CAR-T Halted After Three Deaths While MS Drug Shows Late-Stage Promise

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.

Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?

Simply Wall St.

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Circio boosts circVec gene therapy data and secures funding runway to 2030

Political and General News Events from August 31

GenSci161 Injection Clinical Trial Application of Changchun High-Tech Subsidiary Accepted by Regulator

CSPC Pharma Advances Weight Management Pipeline With Phase 1 Trial Kickoff

OCUMENSION-B's Dry Eye Candidate OT-202 Commences Late-Stage Dosing in China

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/IBBQ/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.472,"timestamp":1789156800000,"preClose":34.41,"halted":0,"volume":17428,"hourTrading":{"tag":"盘后","latestPrice":34.46,"preClose":34.472,"latestTime":"19:30 EDT","volume":73,"amount":2503.222,"timestamp":1789169407321,"change":-0.012,"changeRate":-0.000348,"amplitude":0},"delay":0,"changeRate":0.001801801801801939,"floatShares":2780001,"shares":2780001,"eps":0,"marketStatus":"Market Closed","change":0.062,"latestTime":"09-11 16:00:00 EDT","open":34.93,"high":34.93,"low":34.46,"amount":602342.09186,"amplitude":0.013659,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":34.41,"sharesOutstanding":2520001,"nav":34.42313,"aum":95742920.24,"dividendRate":0.007487,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.46,"preClose":34.472,"latestTime":"19:30 EDT","volume":73,"amount":2503.222,"timestamp":1789169407321,"change":-0.012,"changeRate":-0.000348,"amplitude":0},"volumeRatio":0.8243229216538044,"impliedVol":0.1122,"impliedVolPercentile":0.4701},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2780001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8243229216538044,"shares":2780001,"dividePrice":0.2581,"high":34.93,"amplitude":0.013659,"preClose":34.41,"low":34.46,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.472,"eps":0,"divideRate":0.007487,"volume":17428,"delay":0,"ttmEps":0,"open":34.93,"prevYearClose":28.3962,"prevWeekClose":36.05,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":36.26,"twentyDayClose":33.9144,"sixtyDayClose":29.6382},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664568448","title":"Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664568448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664568448?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:49","pubTimestamp":1788263354,"startTime":"0","endTime":"0","summary":"FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreementsSept 1 (Reuters)-U.S. President Donald Trump has struck drug-pricing deals with more than 20 pharmaceutical co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T0TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000BZT7R73.USD","BMY","IE00BKVL7J92.USD","LU2111349929.HKD","LU1894683348.USD","LU1221951046.USD","LU1718418525.SGD","LU2087625088.SGD","IE00BLSP4452.SGD","LU1074936037.SGD","LU2403377893.USD","SG9999018865.SGD","SG9999017495.SGD","NVS","LU2108987350.USD","LU2552382132.HKD","LU1066053197.SGD","LU2471134952.CNY","LU2360106947.USD","LU0661504455.SGD","LU1989772923.USD","LU1712237335.SGD","SG9999014914.USD","LU0072461881.USD","LU2756315318.SGD","LU1988902786.USD","BK4533","LU0124676726.USD","BK4588","LU2028103732.USD","LU2347655156.SGD","BK7067","MEDI","LU0238689110.USD","IE0002141913.USD","LU0154236417.USD","LU0321505439.SGD","LU1974910355.USD","LU0943347566.SGD","NVO","LU1059921491.USD","IE00B4R5TH58.HKD","LU1201861249.SGD","IE00B4JS1V06.HKD","IE00BFXG1179.USD","LU2023250843.SGD","04332","LU1232071149.USD","LU0158827781.USD","LU0162691827.USD","LU0234572021.USD","IE00BK4W5L77.USD","LU1267930490.SGD","SG9999014880.SGD","SG9999014559.SGD","IE00B19Z3581.USD","LU1116320737.USD","IE00BKPKM429.USD","BK4585","LU0965509101.SGD","LU1127390331.HKD","HRTS","LU0417517546.SGD","IE00BFSS8Q28.SGD","BMED","LU0345769631.USD","LU0994945656.USD","LU0787776722.HKD","LU0511384066.AUD","IE000MB6IJN5.SGD","LU1228905540.USD","LU1868837300.USD","LU2087621335.USD","LU2133065610.SGD","SGXZ31699556.SGD","IBB","LU0949170772.SGD","LU2324357040.USD","LU1979441026.SGD","LU2360032135.SGD","AZN","LU1066051225.USD","BK4566","IE000SO60NU8.SGD","LU1244550221.USD","LU0965508806.USD","LU1778281490.HKD","LU0306806265.USD","IE00BVYPNW00.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0545562505.USD","IE000F7OJYX1.SGD","SGXZ99366536.SGD","SG9999014542.SGD","IE0009355771.USD","LU1267930813.SGD","BIB","LU0203347892.USD","XLV","LU0256863811.USD","RXL","GSK","LU0109394709.USD","LU2362541273.HKD","SGXZ80539844.SGD","LU2596442595.SGD","SGXZ57979304.SGD","LU2750360641.GBP","SG9999011175.SGD","SG9999015358.SGD","LU1280957306.USD","IE00B7SZLL34.SGD","LU0094547139.USD","LU0820561909.HKD","PFE","LU0158827948.USD","LU0708995401.HKD","LU1868837136.USD","IE0000B7K699.USD","LU0079474960.USD","LU1035775433.USD","LU0738911758.USD","SG9999002224.SGD","LU0316494557.USD","LU0267386448.USD","LU0882574055.USD","LU0640476718.USD","LU0820562030.AUD","LU1804176565.USD","BK4599","LU0320765489.SGD","LU1244550577.SGD","BBH","LU2357627491.SGD","LU0868494708.USD","MRK","LU1674673428.USD","NVOC","IE00BN8TJ469.HKD","LU0097036916.USD","LU0354030438.USD","LU2125909593.SGD","LU1720051108.HKD","LU0170899867.USD","LU0964807845.USD","LU0820561818.USD","LU1037948897.HKD","NVOH","LU2211815571.USD","LU1066051811.HKD","LU1732799900.SGD","LU2112291526.USD","LU2462157665.USD","LU1093756168.USD","LU0061475181.USD","LU0689626769.HKD","LU0320765646.SGD","IE00BJLML261.HKD","LU0211327993.USD","LU2347655073.USD","BK4516","LU0912757837.SGD","LU1366192091.USD","LU2505996681.GBP","SG9999014575.USD","LU0310799852.SGD","LU2264538146.SGD","IE00B2B36J28.USD","LU1023059063.AUD","LU1003077747.HKD","LU0965509283.SGD","LU0211331839.USD","LU1496350171.SGD","LU1670710661.SGD","FHLC","LU1066051498.USD","THNR","LU1196500208.SGD","LU1244550494.USD","LU0225771236.USD","FTXH","MHIP","IE00BFSS7M15.SGD","LU0265550946.USD","CURE","LU1093756325.SGD","LU1670710588.SGD","LU2461242641.AUD","LU1868836914.USD","LU2491050071.SGD","LU0795875169.SGD","LU1228905037.USD","LU1934455194.USD","LU1267930730.SGD","BK0239","REGN","LU0466842654.USD","LU0859254822.USD","LU2468319806.SGD","BK4007","LU0234570918.USD","IE00BJJMRX11.SGD","LU2023251221.USD","LU1064131342.USD","LU1914381329.SGD","LU2237438978.USD","LU0069063385.USD","LU0889566641.SGD","LU0553294199.USD","LU2756315664.SGD","GILD","IE0004445239.USD","LU0174119429.USD","LU1670711040.USD","LU1236620834.HKD","LU1989771016.USD","LU0868494617.USD","IXJ","TRUH","LU1236620750.USD","LU2487616109.SGD","AZNH","LU0889565916.HKD","LU1116320901.HKD","IE0004445015.USD","IE00BVYPNV92.GBP","LU0708994859.HKD","IE00B7KXQ091.USD","IE0034235303.USD","LU1934455277.USD","LU0471298694.HKD","LU2089283258.USD","LU0130517989.USD","AMGN","LU1670711123.USD","LU1043141396.HKD","LU0029864427.USD","LU1551013342.USD","LU1670628061.USD","LU1868836591.USD","SG9999015986.USD","SG9999018857.SGD","LU0353189680.USD","LU2168564222.USD","LU1145028129.USD","SG9999013999.USD","BK4532","SG9999015952.SGD","IE000WAW04H5.SGD","IE00BWXC8680.SGD","LU0320765059.SGD","IE00BLSP4239.USD","LU2265009873.SGD","CSL.AU","BK4592","LU0980610538.SGD","LU0683600562.USD","LU2168564065.EUR","LU0114720955.EUR","LU2471134879.HKD","IYH","LU2746668974.SGD","LU1623119135.USD","AGNG","LU0130102774.USD","LU0385154629.USD","LU1221951129.SGD","GSK.UK","LU0426412945.USD","LU0823434740.USD","LU0058720904.USD","LU2746668461.USD","LU0098860793.USD","LU2462591350.SGD","LU2089984988.USD","LU0225284248.USD","LU2242652126.USD","LLY","688235","IE00B1XK9C88.USD","LU2168563687.JPY","LU1629891620.HKD","LU0471298777.SGD","LU2089284900.SGD","SG9999003800.SGD","LU1037948541.HKD","LU2552382215.SGD","BK7501","TBXU","LU1934455863.HKD","IE00BN29S564.USD","LU0006306889.USD","LU0792757196.USD","LU0823416689.USD","LU0726765562.USD","BK4504","LU1323610961.USD","LU1032955483.USD","LU2271345857.HKD","LLYX","LU1506573853.SGD","LU1057294990.SGD","IE00BZ1G4Q59.USD","LU1430594728.SGD","LU0345769128.USD","LU0942090050.USD","TMED","LU1829250122.USD","SGXZ51526630.SGD","SG9999014567.USD","06160","IE00BJJMRY28.SGD","LU1032466523.USD","LU1261432733.SGD","LU2168564149.EUR","LU2125154778.USD","LU0353189763.USD","LU0395794307.EUR","OZEM","LU2362540622.SGD","LU0070302665.USD","IE00BBT3K403.USD","LU0472753341.HKD","SG9999015945.SGD","LU0265550359.USD","LU0096364046.USD","LU0256863902.USD","LU2168564495.EUR","IHE","LU1035773651.USD","LU1069344957.HKD","LU2505996509.AUD","IE00B19Z3B42.SGD","IE00BGHQF631.EUR","LU1699723380.USD","WDNA","LU1496350502.SGD","SG9999001176.SGD","PAWZ","LU1814569148.SGD","VHT","LU1917777945.USD","LU2213496289.HKD","SG9999001176.USD","IE00B775H168.HKD","BK4139","LU0237698245.USD","SG9999014906.USD","BK4578","LU2129689605.HKD","LU2417539215.USD","GDOC","LU0672654240.SGD","LU0266013472.USD","LU1043141123.HKD","LU1989772840.SGD","LU2433249047.HKD","LU0203202063.USD","PBE","IE00B3PB1722.GBP","LU1941712264.USD","LLYZ","LU0456855351.SGD","CANC","LU0648001328.SGD","BK7508","BK7511","LU2491049909.HKD","LU1894683264.USD","LLII","LU0965509010.AUD","LU0203201768.USD","IE0001KFT4U8.USD","LU1983299246.USD","LU0128525929.USD","BBIO","LU2237443549.SGD","LU2602419157.SGD","LU2361044865.SGD","LU2357305700.SGD","LU0310800379.SGD","ELIS","IE0002270589.USD","LU1941712348.USD","LU2471134523.USD","JDOC","BK4581","GLAM","LU2592432038.USD","PJP","LU0545039389.USD","LU2129689514.USD","IE000M9KFDE8.USD","LU2125154935.USD","LU0786609619.USD","LU0861579265.USD","PPH","SG9999015978.USD","LU1691799644.USD","LU0106261372.USD","LU0795875086.SGD","LU1732800096.USD","LU1839511570.USD","LU0426417589.USD","LU1674673691.USD","LU0345770993.USD","LU2237443622.USD","LU0109391861.USD","LU2362541513.USD","SG9999002232.USD","LU2242646821.SGD","MEDX","SG9999001440.SGD","LU0070217475.USD","IE0005OL40V9.USD","LU0306807586.USD","IE00BSNM7G36.USD","ONC","LU2237443895.HKD","LU0211328371.USD","LU2430703095.HKD","LU0198837287.USD","LU2896262040.SGD","LU0203345920.USD","LU2129689431.USD","LU2456880835.USD","LU0289739343.SGD","IE00BK4W5M84.HKD","LU1121112475.USD","BK4505","IE00B42XCP33.USD","ELIL","IE00BDGV0183.EUR","LU0985320562.USD","LU0882574139.USD","IE00B3T34201.USD","LU0323591593.USD","LU1061106388.HKD","SG9999014898.SGD","IE00BKDWB100.SGD","SGXZ81514606.USD","LU0208291251.USD","NVOX","LU2750360997.AUD","LU2361044949.HKD","LU1670627923.USD","LU2361045086.USD","LU0133085943.USD","LU2430703178.SGD","ILDR","LU2471134796.USD","LU1571399168.USD","ABBV","LU1923622614.USD","BK4559","BK4550","IE00BFTCPJ56.SGD","LU0689472784.USD","LU0345770308.USD","LU0210528500.USD","LU2491050154.USD","LU0122379950.USD","JNJ","LU0985481810.HKD","LU1551013425.SGD","IBBQ","LU0477156953.USD","LU0321505868.SGD","LU0057025933.USD","LU0320765992.SGD","LU1585245621.USD","BK4583","LU1935042991.SGD","LU0354030511.USD","LU1929549753.HKD","LU2430703251.USD","LU0289961442.SGD","LU2552382058.USD","BK4568","LU0225283273.USD","LU2236285917.USD","LU0432979614.USD","LU1883839398.USD","LU1548497426.USD","GSKH","LU2023250330.USD","LU1720051017.SGD","LU2125909247.SGD","SG9999015341.SGD","LU2063271972.USD","LU2237443978.SGD","LU2237443382.USD","BK4534","LU1868836757.USD","GB00BDT5M118.USD","LU0823434583.USD","LU2023250504.SGD","LU2106854487.HKD","LU1069347547.HKD","LU0210536198.USD","LU2237443465.HKD","IE00B1BXHZ80.USD","LU0053666078.USD","LU1162221912.USD","LU1291159041.SGD","LU1267930573.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664385377","title":"UK Regulator Suspends Avacopan Vifor for New Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2664385377","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664385377?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:03","pubTimestamp":1788260615,"startTime":"0","endTime":"0","summary":"The UK's health regulator has suspended the use, supply and sale of Avacopan Vifor, previously known as Tavneos, for new patients from Sept. 1, the watchdog said Tuesday.The Medicines and Healthcare products Regulatory Agency said available evidence no longer supports a positive benefit-risk balance for the medicine, which is used to treat some rare autoimmune diseases affecting small blood vessels.Tavneos was originally developed by ChemoCentryx, which was acquired by Amgen  in 2022, according to Amgen's website.The regulator said it reached its decision after reviewing all available evidence, advice from the Commission on Human Medicines, and feedback from patients and healthcare professionals.The supply will be allowed to existing patients during a six-month managed withdrawal period to allow safe alternative treatment options, the regulator said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TBXU","BK4534","IE0002141913.USD","BK4566","LU0122379950.USD","LU2468319806.SGD","BBH","LU2112291526.USD","BK4533","IE00B4R5TH58.HKD","AMGN","LU1571399168.USD","BK4581","BK4599","IE00BJT1NW94.SGD","BK4585","LU0058720904.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU2242646821.SGD","LU0868494617.USD","IBB","PBE","LU0889565916.HKD","BIB","LU1057294990.SGD","BK4588","LU1061106388.HKD","BK4139","LU1983299246.USD","IBBQ","PJP","LU2242652126.USD","LU0109394709.USD","LU1023059063.AUD","LU2089984988.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU0289739699.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664985383","title":"Novartis halts autoimmune CAR-T trials following three deaths, Reuters says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664985383","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664985383?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:30","pubTimestamp":1788258648,"startTime":"0","endTime":"0","summary":"Novartis (NVS) has paused eight clinical trials of rap-cel, an experimental cell therapy targeting autoimmune and neurological disorders, after thr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765489.SGD","IE00B2B36J28.USD","BK4532","BK4007","FBT","GNOM","LU0208291251.USD","IE00BFTCPJ56.SGD","NVIB","IDNA","IE0002141913.USD","CNCR","BK4588","NVS","HYLG","MEDX","SYNB","IE00BJJMRZ35.SGD","LU0211331839.USD","PPH","IBB","LFSC","BK4578","LU0070302665.USD","IBBQ","TBXU","IE00BJT1NW94.SGD","GDOC","BMED","IE0009355771.USD","BK4585","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664287830","title":"Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664287830","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664287830?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:40","pubTimestamp":1788255621,"startTime":"0","endTime":"0","summary":"Goldman Sachs analysts added Vertex Pharmaceuticals (VRTX) to the firm’s US Conviction List as part of its monthly update. Goldman believes Vertex ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-conviction-list-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-conviction-list-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4504","BBH","IE0002141913.USD","LU0106831901.USD","IE00BJT1NW94.SGD","GNMX","IE0004091025.USD","VERX","LU0868494708.USD","LU1430594728.SGD","SGXZ57979304.SGD","LU2471134796.USD","LU1585245621.USD","IBBQ","IE00B19Z3581.USD","LU2471134952.CNY","PBE","LU0432979614.USD","LU1778281490.HKD","BIB","GSX","LU0417517546.SGD","LU1668664300.SGD","LU2362540622.SGD","VRTX","BK4127","LU0757428866.USD","IE00B2B36J28.USD","IE00B894F039.SGD","LU2471134879.HKD","IE0002270589.USD","LU1815336091.USD","LU2237443895.HKD","LU2362541513.USD","IE0034235188.USD","IE00BZ9MQY76.HKD","LU2237443382.USD","TBXU","IE00BSNM7G36.USD","IDNA","LU1894683264.USD","LU2089984988.USD","LU1868836914.USD","LU2236285917.USD","LU2362541273.HKD","LU1093756325.SGD","LU1035775433.USD","LU0345770993.USD","IE00BFTCPJ56.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664837149","title":"UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September","url":"https://stock-news.laohu8.com/highlight/detail?id=2664837149","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664837149?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:29","pubTimestamp":1788254980,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44S0UF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","IE0002141913.USD","LU0889565916.HKD","TBXU","LU1061106388.HKD","PBE","IE00B4R5TH58.HKD","IBB","IE00B2B36J28.USD","LU1023059063.AUD","AMGN","LU2242646821.SGD","SG9999001440.SGD","BK4581","LU0058720904.USD","PJP","LU1057294990.SGD","LU1571399168.USD","BK4585","BK4566","LU2089984988.USD","BK4534","LU2242652126.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU2468319806.SGD","BK4139","IE00BJJMRZ35.SGD","BK4599","LU0868494617.USD","LU1983299246.USD","LU0122379950.USD","LU2112291526.USD","BBH","BK4533","IE0009355771.USD","BK4588","BIB","IBBQ","LU0289739699.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116658661","title":"Zhifei Biological's Freeze-Dried Rabies Vaccine Candidate Receives Clinical Trial Application Acceptance","url":"https://stock-news.laohu8.com/highlight/detail?id=1116658661","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116658661?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:13","pubTimestamp":1788253990,"startTime":"0","endTime":"0","summary":"Chongqing Zhifei Biological Products Co.,Ltd. (300122.SZ) has announced that its wholly-owned subsidiary, Anhui Zhifei Longcom Biopharmaceutical Co., Ltd., has received the acceptance notice for a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2580892789.USD","MDTX","300122","IBBQ","LU2580892862.HKD","159646","LU1064131003.USD","BK0239","PSYK","BK0077","LU1328615791.USD","IBBJ","BMED","BK0196","BK0046","LU2148510915.USD","LU1064130708.USD","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147997181","title":"Centergate Subsidiary Gains Clinical Trial Clearance for Methylphenidate Prolonged-Release Chewable Tablet","url":"https://stock-news.laohu8.com/highlight/detail?id=1147997181","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147997181?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:03","pubTimestamp":1788253380,"startTime":"0","endTime":"0","summary":"Beijing Centergate Technologies (Holding) Co., Ltd. has announced that its subsidiary, Beijing Huasu Pharmaceutical Co., Ltd., recently obtained a \"Drug Clinical Trial Approval Notice\" from China's...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK0178","BK0075","BK0028","000931","BK0239","PSYK","BMED","IBBJ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664832384","title":"Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664832384","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664832384?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:18","pubTimestamp":1788250703,"startTime":"0","endTime":"0","summary":"Amgen (NasdaqGS:AMGN) reported new Phase 3 VESALIUS-CV trial results for Repatha (evolocumab) showing a reduction in risk of death for high-risk adults without prior heart attack or stroke, presented at the European Society of Cardiology Congress 2026.\nThe findings extend evidence for Repatha to a broader high-risk population beyond patients with established cardiovascular events.\nAmgen highlighted that the data may inform future treatment guidelines and prescribing decisions in...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/why-is-amgen-amgn-in-focus-after-new-repatha-survival-data","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/why-is-amgen-amgn-in-focus-after-new-repatha-survival-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0289739699.SGD","IBBQ","IE0009355771.USD","BK4599","IE00B2B36J28.USD","PJP","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0122379950.USD","BK4533","BBH","LU1023059063.AUD","LU2112291526.USD","BK4534","LU2468319806.SGD","BK4139","LU2242646821.SGD","LU1983299246.USD","AMGN","LU2089984988.USD","LU0320765992.SGD","IBB","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1571399168.USD","BK4581","PBE","TBXU","BK4566","BIB","BK4585","LU2242652126.USD","LU0868494617.USD","LU0058720904.USD","IE0002141913.USD","SG9999001440.SGD","LU1061106388.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132713513","title":"Novartis Faces Dual Outcomes: CAR-T Halted After Three Deaths While MS Drug Shows Late-Stage Promise","url":"https://stock-news.laohu8.com/highlight/detail?id=1132713513","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132713513?lang=en_us&edition=fundamental","pubTime":"2026-09-01 15:50","pubTimestamp":1788249011,"startTime":"0","endTime":"0","summary":"Swiss pharmaceutical giant Novartis AG (NVS.US) is experiencing a stark contrast in its neuro-immunology pipeline, as progress in one area is overshadowed by a serious setback in another. The company...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","IE0002141913.USD","BK4532","BK4585","BK1574","BK4578","PSYK","IBBJ","BMED","MDTX","PPH","IE0009355771.USD","LU0208291251.USD","MEDX","LU0320765489.SGD","IE00BJJMRZ35.SGD","LU0070302665.USD","BK1191","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4007","IE00BJT1NW94.SGD","IBBQ","BK4588","LU0211331839.USD","NVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838571","title":"Vertex Advances Share Buyback, Acquires 445,500 Shares by August","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838571","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838571?lang=en_us&edition=fundamental","pubTime":"2026-09-01 12:22","pubTimestamp":1788236545,"startTime":"0","endTime":"0","summary":"Vertex Corp. ( ($JP:5290) ) has provided an announcement. Vertex Corporation reported the progress of its ongoing share buyback program, authorized...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1778281490.HKD","LU0320765992.SGD","LU1674673428.USD","BRKC","LU2237438978.USD","IE0002141913.USD","LU0417517546.SGD","LU1585245621.USD","VRTX","ACTV","BK4139","BBH","BRKL","LU0889565916.HKD","LU0757428866.USD","LU1815336091.USD","IBB","IE00B19Z9P08.USD","LU0109394709.USD","LU1069344957.HKD","LU2456880835.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","VERX","SG9999001176.USD","IE00BJT1NW94.SGD","BRKD","BK4567","LU0061475181.USD","LU1430594728.SGD","LU2362541513.USD","LU2462157665.USD","IE00BZ9MQY76.HKD","ACKY","IE00B2B36J28.USD","BIB","IE00BJJMRZ35.SGD","BRKU","LU1559883803.SGD","IBBQ","BRKW","LU0256863811.USD","LU0058720904.USD","LU1035775433.USD","TBXU","LU0234570918.USD","GNMX","PBE","BK4588","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838493","title":"Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838493","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838493?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:20","pubTimestamp":1788229256,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals has delivered strong long term gains over the past five years, yet current valuation checks suggest the stock now looks closer to fairly priced than clearly cheap. For investors, the question is how that past share price performance lines up with what the broader valuation signals are saying today.\n\nThe stock has returned 174.9% over five years, which puts extra focus on whether recent strength already reflects much of the good news in the story.\nFuture growth in cash...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BBH","IE0002141913.USD","LU0234570918.USD","LU2417539215.USD","GNMX","LU1674673691.USD","LU0889565916.HKD","IE0009355771.USD","IE00B19Z9Z06.USD","SG9999001176.USD","VERX","LU1430594728.SGD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","IBBQ","IE00B19Z3581.USD","LU0823416689.USD","LU2324357040.USD","LU0432979614.USD","LU0566484027.USD","LU1778281490.HKD","PBE","CDIG","BIB","LU2362540622.SGD","VRTX","BK4588","IE00B2B36J28.USD","LU0289739699.SGD","TSPA","LU1674673428.USD","LU1815336091.USD","BK4532","IE00BZ9MQY76.HKD","LU1069344957.HKD","LU1093756168.USD","TBXU","BK4139","IDNA","LU1559883803.SGD","LU2089984988.USD","IE00BJJMRZ35.SGD","LU0079474960.USD","TACU","LU0061475181.USD","LU0109394709.USD","BK4585","SG9999001176.SGD","LU1035775433.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664854881","title":"Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854881","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664854881?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:17","pubTimestamp":1788218267,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals has secured past FDA approval for Pasatru (garetosmab-grts), a VelocImmune-derived monoclonal antibody that reduces new heterotopic ossification lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva, based on Phase 3 OPTIMA trial data.\nThis approval introduces a new rare disease therapy that can be infused monthly, including in home settings, and is supported by strong lesion-reduction outcomes against placebo while carrying...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-pasatrus-rare-disease-approval-with-home-infusion-potenti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-pasatrus-rare-disease-approval-with-home-infusion-potenti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VTHR","REGN","BK4585","LU0889565916.HKD","LU0114720955.EUR","LU2468319806.SGD","LU0823416689.USD","LU2362541273.HKD","BK4588","AIPO","LU2089984988.USD","LU1974910355.USD","BK4195","QTOC","LU0058720904.USD","LU1917777945.USD","CHAT","LU0882574055.USD","AGIX","LU0109394709.USD","LU0053666078.USD","LU2362540622.SGD","HBCP","LU0320765992.SGD","IBB","LU2023250504.SGD","LU0823434583.USD","BBH","BK4139","BK4211","TBXU","LU0289739699.SGD","ARTY","LU0823434740.USD","LU2237438978.USD","LU2106854487.HKD","IBBQ","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664925888","title":"Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2664925888","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664925888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:53","pubTimestamp":1788205998,"startTime":"0","endTime":"0","summary":"UPDATE 2-Trump administration announces drug pricing deals with CSL, Astellas and othersWASHINGTON, Aug 31 (Reuters)-U.S. President Donald Trump announced a new round of drug-pricing agreements with i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0RA:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK0046","BBIO","LU0889565916.HKD","688235","IE00BJT1NW94.SGD","AMGN","TBXU","LU1883839398.USD","BK4505","300485","IE0002270589.USD","LU0321505439.SGD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0320765992.SGD","SG9999001176.SGD","IE00BJJMRZ35.SGD","BK4566","LU0306806265.USD","LU0868494617.USD","LU0225284248.USD","IE00BFTCPJ56.SGD","BK4534","OZEM","PFE","CSL.AU","BBH","BK0028","IBB","PJP","BK0012","SG9999002224.SGD","LU2112291526.USD","LU2242646821.SGD","PBE","BK7511","LU0109394709.USD","IONS","LU2468319806.SGD","IE00B3T34201.USD","BK4550","LU1983299246.USD","LU1894683348.USD","LU1057294990.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","IE0002141913.USD","BK4007","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000711","title":"Circio boosts circVec gene therapy data and secures funding runway to 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000711","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000711?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:03","pubTimestamp":1788203022,"startTime":"0","endTime":"0","summary":"The latest update is out from Targovax ASA ( ($GB:0RIS) ). Circio Holding ASA reported that new preclinical data show its circVec circular RNA tech...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","IE0009354923.USD","LFSC","FBT","RNA","BK4585","BK4588","BK4505","CNCR","SYNB","IBBQ","BK4139","IBB","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663005748","title":"Political and General News Events from August 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2663005748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663005748?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:15","pubTimestamp":1788182117,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 31Aug 31 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S10Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE0002141913.USD","LU0889565916.HKD","TBXU","LU1061106388.HKD","PBE","IE00B4R5TH58.HKD","IBB","IE00B2B36J28.USD","LU1023059063.AUD","AMGN","LU2242646821.SGD","SG9999001440.SGD","BK4581","LU0058720904.USD","PJP","LU1057294990.SGD","LU1571399168.USD","BK4585","BK4566","LU2089984988.USD","BK4534","LU2242652126.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU2468319806.SGD","BK4139","IE00BJJMRZ35.SGD","BK4599","LU0868494617.USD","LU1983299246.USD","LU0122379950.USD","LU2112291526.USD","BBH","BK4533","IE0009355771.USD","BK4588","BIB","IBBQ","LU0289739699.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113021196","title":"GenSci161 Injection Clinical Trial Application of Changchun High-Tech Subsidiary Accepted by Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1113021196","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113021196?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:28","pubTimestamp":1788179298,"startTime":"0","endTime":"0","summary":"Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ) has announced that its majority-owned subsidiary, Changchun Jinsai Pharmaceutical Co., Ltd., recently received the official Acceptance...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","BK0239","BK0188","IBBQ","000661","BMED","BK0046","BK0028","BK0057","BK0075","PSYK","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178504231","title":"CSPC Pharma Advances Weight Management Pipeline With Phase 1 Trial Kickoff","url":"https://stock-news.laohu8.com/highlight/detail?id=1178504231","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178504231?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:00","pubTimestamp":1788177626,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced the official initiation of the first clinical trial site in China for its Phase 1 study of the SYH2092 injection, targeting weight management in adults who are...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0501845795.SGD","BK1515","LU1226287529.USD","IBBQ","LU1813983027.USD","LU1993786604.SGD","IE00B031HY20.USD","LU1951186391.HKD","IE0008369823.USD","IE00BZ08YT58.USD","PSYK","LU0067412154.USD","LU1226287792.SGD","HK0000165453.HKD","BK1521","KURE","LU1807302812.USD","IE00B543WZ88.USD","LU0326950275.SGD","SG9999004220.SGD","LU0072913022.USD","MDTX","BMED","LU1328277881.USD","IE0008368742.USD","LU0314109678.HKD","LU0315179316.USD","01093","LU1008478684.HKD","LU0140636845.USD","LU1152091754.HKD","LU1226287875.USD","LU1226288170.HKD","IE00B5MMRT66.SGD","LU2039709279.SGD","IE00BZ08YR35.GBP","BK1191","LU0880133367.SGD","IBBJ","LU1960683339.HKD","LU1226288253.USD","IE00BZ08YS42.EUR","LU1152091168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131581918","title":"OCUMENSION-B's Dry Eye Candidate OT-202 Commences Late-Stage Dosing in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1131581918","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131581918?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:28","pubTimestamp":1788172096,"startTime":"0","endTime":"0","summary":"OCUMENSION-B (01477) has announced that the first patient has been enrolled in the Chinese Phase III clinical trial for OT-202, its investigational therapy for dry eye disease (DED). This milestone...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","01477","BMED","IBBQ","MDTX","PSYK","BK1574","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071381","title":"Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071381","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663071381?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:51","pubTimestamp":1788169915,"startTime":"0","endTime":"0","summary":"Amgen  said Monday that its cholesterol-lowering drug Repatha reduced the risk of death by 20% in high-risk adults without a prior heart attack or stroke.The findings came from a pre-specified analysis of the phase 3 VESALIUS-CV trial involving more than 12,000 patients and were presented at the European Society of Cardiology Congress 2026 in Munich, it said.Amgen said Repatha reduced both overall and cardiovascular deaths when added to statins or other LDL-C-lowering treatments. The mortality benefit emerged after about 1.5 years and continued through a median follow-up of 4.6 years, it added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1061106388.HKD","LU2089984988.USD","IE00BJJMRZ35.SGD","BBH","LU1057294990.SGD","LU2468319806.SGD","PJP","BIB","LU1571399168.USD","BK4533","SG9999001440.SGD","LU2242646821.SGD","LU0058720904.USD","IBB","LU0320765992.SGD","LU0868494617.USD","PBE","IE00BFTCPJ56.SGD","BK4566","IE0002141913.USD","IE0009355771.USD","LU0122379950.USD","LU2112291526.USD","LU2242652126.USD","BK4534","LU0109394709.USD","BK4581","LU0889565916.HKD","AMGN","BK4585","LU0289739699.SGD","BK4139","IBBQ","LU1023059063.AUD","TBXU","BK4599","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4588","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663249076","title":"Amgen Repatha reduces risk of death in high-risk adults for first heart attack","url":"https://stock-news.laohu8.com/highlight/detail?id=2663249076","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663249076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:10","pubTimestamp":1788167413,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) announced new findings showing Repatha reduced the risk of death in high-risk adults without a prior heart attack or stroke when added...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","LU1983299246.USD","AMGN","BK4581","LU2468319806.SGD","LU2242646821.SGD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0889565916.HKD","IE0002141913.USD","LU1057294990.SGD","LU2089984988.USD","LU2112291526.USD","BIB","BK4588","LU2242652126.USD","LU1061106388.HKD","BK4566","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU0058720904.USD","LU1571399168.USD","IBB","PBE","PJP","IBBQ","BBH","TBXU","IE00BJT1NW94.SGD","BK4139","LU0868494617.USD","LU1023059063.AUD","SG9999001440.SGD","BK4534","BK4599","LU0109394709.USD","LU0122379950.USD","BK4533","IE0009355771.USD","BK4585","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}